Suzhou Sepax Technologies Co., Ltd. (688758.SS) has a MoatMap StockRank of 58/100 based on Quality (78/100), Value (19/100), and Momentum (46/100) factor scores. The current signal is HOLD. Suzhou Sepax Technologies is a premier manufacturer of liquid chromatography media and columns used in the purification of biologics, ADCs, and GLP-1 therapeutics. Because purification is the most critical and expensive step in biologics manufacturing, Sepax possesses immense pricing power and a highly recurring, consumable-driven revenue model that benefits directly from the global CDMO expansion. Its exceptional quality score (Q: 78) reflects its deep technical moat.
Suzhou Sepax Technologies Co., Ltd. specializes in the development and manufacture of liquid chromatography columns and separation media for the purification of biological drugs. The company possesses a strong technological moat based on proprietary surface chemistry and polymer synthesis technologies, which are critical for separating complex biomolecules. It is a key supplier to global biopharmaceutical companies and research institutions.
| Price | $2.82 |
| Market Cap | $1.1B |
| P/E (TTM) | 52.73 |
| P/E (Forward) | 41.43 |
| Price/Book | 5.23 |
| Return on Equity | 11.1% |
| Return on Invested Capital | 10.5% |
| Debt/Equity | 6.85 |
| Gross Margin | 70.5% |
| Operating Margin | 35.9% |
| Revenue Growth | 36.0% |
| Dividend Yield | 0.4% |
| Free Cash Flow | $5M |
Suzhou Sepax Technologies Co., Ltd. operates in the Chemicals industry, part of the Basic Materials sector (China).